Clinica Baviera (CBAV) Q1 2026 earnings summary

Executive summary

• Revenue grew 8% year-over-year in Q1 2026, reaching €86.97 million, with all major markets contributing to growth.

• Net income increased 14% year-over-year to €14.7 million, reflecting improved profitability.

• Expansion continued with new clinic openings in Spain, Italy, and Germany, supporting sales growth.

Financial highlights

• EBITDA rose 9% year-over-year to €26.37 million, with margin improvements in Spain and Italy.

• EBIT increased 7% to €19.73 million, and profit before taxes was up 11% to €20.11 million.

• Cash and equivalents rose to €64.84 million, up €14.51 million from year-end 2025.

• Net financial position improved to €57.42 million, a €15.02 million increase from December 2025.

Outlook and guidance

• Business performance remains in line with plans, with continued focus on expanding clinical capacity and reducing waiting times.